oncgnostics GmbH

Develops IVD tests for screening;therapeutic decision making;and follow-up care in cancer diagnostics

Total raised

€1.0M

€1,000,000

Funding rounds

Investors

distinct backers

Active since

2017-01

latest 2023-09

Funding by year

EUR raised per year

Medium confidence

Raise-next likelihood22

base rate 30% for Other

Exit likelihood13

base rate 12% (2+ rounds)

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

2 rounds

Date	Stage	Amount	Investors
2023-09-11	Other	—	Grande Bio-tech Co.	View deal →
2017-02-01	Early VC	€1.0M	bm-t Beteiligungsmanagement Thüringen GmbH	View deal →

same sector or country